CD8A and myeloid sarcoma: CD161 is a transmembrane cell surface molecule which is expressed on CD4+ and CD8+ T-cells, and a single nucleotid polymorphism of the CD161 gene (KLRB1) has been associated with susceptibility to develop MS [21].